Autoimmune Pulmonary Alveolar Proteinosis Completed Phase 1 Trials for Pioglitazone (DB01132)

Back to Autoimmune Pulmonary Alveolar Proteinosis

Also known as: Pulmonary Alveolar Proteinosis, Autoimmune / Autoimmune pulmonary alveolar proteinosis (disorder) / Alveolar proteinosis / Pulmonary Alveolar Proteinosis / Pulmonary alveolar proteinosis (disorder)

IndicationStatusPhase
DBCOND0075037 (Autoimmune Pulmonary Alveolar Proteinosis)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03231033
Pioglitazone Therapy of Autoimmune Pulmonary Alveolar Proteinosis Autoimmune Pulmonary Alveolar ProteinosisBasic Science